USD 1.1
(-5.17%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 3.84 Million USD | -64.6% |
2022 | 14.67 Million USD | 15.05% |
2021 | 12.75 Million USD | 13.79% |
2020 | 11.21 Million USD | -10.92% |
2019 | 12.58 Million USD | 118.23% |
2018 | 5.76 Million USD | 697.88% |
2017 | 722.8 Thousand USD | 6633.83% |
2016 | 10.73 Thousand USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | -150.2 Thousand USD | 98.28% |
2023 Q1 | 1.82 Million USD | -41.07% |
2023 Q3 | 653.64 Thousand USD | -44.05% |
2023 Q2 | 1.16 Million USD | -36.06% |
2023 FY | 4.79 Million USD | -67.34% |
2023 Q4 | -8.71 Million USD | -1434.02% |
2022 Q1 | 3.43 Million USD | -9.21% |
2022 Q4 | 3.1 Million USD | -11.58% |
2022 FY | 14.67 Million USD | 15.05% |
2022 Q3 | 3.5 Million USD | -24.36% |
2022 Q2 | 4.63 Million USD | 34.98% |
2021 Q4 | 3.78 Million USD | 21.0% |
2021 Q3 | 3.12 Million USD | 0.03% |
2021 FY | 12.75 Million USD | 13.79% |
2021 Q1 | 2.72 Million USD | -10.81% |
2021 Q2 | 3.12 Million USD | 14.79% |
2020 Q4 | 3.05 Million USD | 0.12% |
2020 FY | 11.21 Million USD | -10.92% |
2020 Q3 | 3.04 Million USD | 40.7% |
2020 Q1 | 2.94 Million USD | -26.78% |
2020 Q2 | 2.16 Million USD | -26.33% |
2019 Q2 | 2.82 Million USD | 21.22% |
2019 FY | 12.58 Million USD | 118.23% |
2019 Q4 | 4.01 Million USD | 17.98% |
2019 Q3 | 3.4 Million USD | 20.38% |
2019 Q1 | 2.33 Million USD | -15.59% |
2018 Q1 | 230.71 Thousand USD | -31.66% |
2018 FY | 5.76 Million USD | 697.88% |
2018 Q4 | 2.76 Million USD | 26.48% |
2018 Q3 | 2.18 Million USD | 272.92% |
2018 Q2 | 586.12 Thousand USD | 154.04% |
2017 Q1 | -141.1 Thousand USD | 0.0% |
2017 Q2 | -172.52 Thousand USD | -22.26% |
2017 Q3 | 282.39 Thousand USD | 263.69% |
2017 FY | 722.8 Thousand USD | 6633.83% |
2017 Q4 | 337.6 Thousand USD | 19.55% |
2016 FY | 10.73 Thousand USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Acadia Healthcare Company, Inc. | 682.6 Million USD | 99.436% |
Addus HomeCare Corporation | 339.87 Million USD | 98.868% |
AirSculpt Technologies, Inc. | 121.9 Million USD | 96.843% |
Amedisys, Inc. | 457.07 Million USD | 99.158% |
American Oncology Network, Inc. | 66.05 Million USD | 94.174% |
Astrana Health, Inc. | 214.95 Million USD | 98.21% |
Aveanna Healthcare Holdings Inc. | 595.43 Million USD | 99.354% |
biote Corp. | 127.48 Million USD | 96.981% |
Cryo-Cell International, Inc. | 22.9 Million USD | 83.195% |
Cross Country Healthcare, Inc. | 432.06 Million USD | 99.109% |
COMPASS Pathways plc | -242.93 Thousand USD | 1684.198% |
DocGo Inc. | 178.95 Million USD | 97.849% |
The Ensign Group, Inc. | 590.75 Million USD | 99.349% |
Healthcare Services Group, Inc. | 251.45 Million USD | 98.469% |
InnovAge Holding Corp. | 132.06 Million USD | 97.086% |
Assure Holdings Corp. | -2.19 Million USD | 275.416% |
The Joint Corp. | 107.14 Million USD | 96.408% |
LifeStance Health Group, Inc. | 302.09 Million USD | 98.726% |
Mobile-health Network Solutions Class A Ordinary Shares | -1.07 Million USD | 459.132% |
ModivCare Inc. | 446.95 Million USD | 99.139% |
NewGenIvf Group Limited | 1.68 Million USD | -128.841% |
Novo Integrated Sciences, Inc. | 4.95 Million USD | 22.293% |
Option Care Health, Inc. | 981.22 Million USD | 99.608% |
P3 Health Partners Inc. | 31.63 Million USD | 87.834% |
P3 Health Partners Inc. | 31.63 Million USD | 87.834% |
The Pennant Group, Inc. | 61.9 Million USD | 93.783% |
Surgery Partners, Inc. | 529.4 Million USD | 99.273% |
Syra Health Corp. Class A Common Stock | 1.41 Million USD | -172.584% |
Talkspace, Inc. | 74.38 Million USD | 94.826% |
Talkspace, Inc. | 74.38 Million USD | 94.826% |
The Oncology Institute, Inc. | 59.57 Million USD | 93.54% |
The Oncology Institute, Inc. | 59.57 Million USD | 93.54% |